EUCTR2006-004441-42-GB进行中(未招募)1 期
A study to evaluate the role of tacrolimus ointment (Protopic®) 0.1% in the treatment of chronic otitis externa.
Southport and Ormskirk Hospital NHS Trust0 个研究点开始时间: 2006年12月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Male or female patient, aged 18 or older, regardless of race.
- •2.Patient has been diagnosed with bilateral chronic eczematous otitis externa and has received standard treatment at the ENT clinic for 6 months without having achieved satisfactory clinical control of the condition.
- •3.Women of child bearing potential must use an acceptable method of birth control prior and have a negative urine pregnancy test prior to study entry.
- •4.Subjects must demonstrate their willingness to participate in the study and comply with its procedures by signing a written informed consent.
- •5.Subjects should not receive vaccinations during the study or 14 days before or after the study. In case of live attenuated vaccination, this period should be extended to 28 days before or after the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Patient is less than 18 years of age.
- •2.Patient is allergic or intolerant to macrolide antibiotics, tacrolimus, and/or its excipients.
- •3.Patient with malignancy or history of malignancy except non-metastatic basal or squamous cell carcinoma of the skin that has been treated successfully.
- •4.Subjects currently receiving immunosuppressive drugs.
- •5.Patient is participating or has participated in another investigational drug trial or is receiving or has received an investigational drug within the last 28 days before entry into this study.
- •6.Patient has been previously enrolled in this study.
- •7.Patient is unlikely to comply with the visits scheduled in the protocol.
- •8.Patient has any form of substance abuse, psychiatric disorder or condition which, in the opinion of the investigator, may invalidate communication with the investigator
- •9.Patient is pregnant or a breast-feeding mother.
研究者
相似试验
招募中
不适用
Examination of efficacy and safety of tacrolimus, immunomodulator for an outpatient with moderate to severe ulcerative colitisulcerative colitisJPRN-UMIN000005824Juntendo University20
已完成
不适用
A randomized controlled study of tacrolimus for the treatment of idiopathic membranous nephropathyIdiopathic membranous nephropathyUrological and Genital DiseasesISRCTN17977921The First Affiliated Hospital of Zhengzhou University (China)120
进行中(未招募)
不适用
Clinical study on tacrolimus ointment over the long-termControl Study - Children”Revised version of FG-506-06-39 - Control Study - ChildreAtopic DermatitisEUCTR2004-001644-80-HUFujisawa GmbH200
已完成
1 期
A pharmacological study of tacrolimus ointmentAtopic dermatitisJPRN-jRCT1080225219Maruho Co.,Ltd.20
已完成
4 期
A comparative study of the efficacy of tacrolimus with infliximab in intractable ulcerative colitislcerative colitisJPRN-UMIN000010612Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine130
